Better Long-Term Buy: This Emerging Player or the Industry Leader?

2026-01-30 15:50:00 ET

AbbVie (NYSE: ABBV) is one of the largest pharmaceutical companies in the world. Though its portfolio spans many therapeutic areas, it is particularly well known for its work in immunology, a field in which it boasts some of the best-selling therapies. However, many smaller drugmakers are trying to break into this space.

One of them, Abivax (NASDAQ: ABVX) , has grabbed quite a few headlines of late thanks to a potentially transformative immunology medicine still in development. Should investors opt for the well-established giant or the up-and-coming challenger?

Image source: Getty Images.

Continue reading